English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 6 June 2019, 10:00 HKT/SGT

Source: AcroMeta Group Limited
ACROMEC Signs LOI for Collaboration to Own-Operate Private Fertility Centre
- Two renowned medical specialists as core management team
- Leading US fertility centre to be strategic investor and adviser
- ACROMEC to acquire the premises and equipment for the fertility centre

SINGAPORE, June 6, 2019 - (ACN Newswire) - ACROMEC Limited ("ACROMEC", or the "Company" and together with its subsidiary, the "Group"), an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biomedical, research and academia sectors, today announced that the Company has entered into a letter of intent ("LOI") for a proposed collaboration to own and operate a private fertility center. The LOI sets out the principal terms of the proposed collaboration.

The LOI is entered into with two renowned specialists in the field of fertility medicine who will lead the core management team, and with a leading US fertility centre as strategic investor and adviser.

The assets required for the operation of the centre, such as the premises and equipment are intended to be acquired by ACROMEC from a former customer of the Group which has now been placed under judicial management.

The Board believes that the proposed collaboration presents a strategic opportunity for the Group to raise its core engineering services business to the next higher value-add level. The Group is working towards a turn-key model where it can source for the funding, design, build, and outfit of medical facilities, to lease out or self-operate upon completion.

Commenting on the LOI, Mr Lim Say Chin, Executive Chairman and Managing Director of ACROMEC, said, "This proposed collaboration is an opportunity to participate in the growth of the fertility business in the region. The high economic growth of the countries in the region, as well changes in demographics and developments in procreation sciences has spawned a strong demand for medical fertility services."

About ACROMEC Limited (SGX Stock Code: 1CH1)

ACROMEC is an established specialist engineering services provider with more than 20 years of experience in the field of controlled environments. The Group has over the years acquired expertise in the design and construction of facilities requiring controlled environments such as laboratories, medical and sterile facilities and cleanrooms.

ACROMEC's business is divided into two main business segments: (i) Engineering, procurement and construction services, specialising in architectural, and mechanical, electrical and process works within controlled environments; and (ii) Maintenance and repair services of facilities and equipment of controlled environments and their supporting infrastructure.

The Group mainly serves the healthcare, pharmaceutical, biomedical science, research and academia, and electronics sectors. ACROMEC counts amongst its customers, hospitals and medical centres, government agencies, research and development companies or agencies, research and development units of multinational corporations, tertiary educational institutions, pharmaceutical companies, semiconductor manufacturing companies, and multinational engineering companies. For more information, please visit www.ACROMEC.com.

Media and Analysts Contact:
Mr Jerry Tan
Chief Financial Officer
Tel: +65 6415 0574
Email: jerry.tan@ACROMEC.com

Waterbrooks Consultant Pte Ltd
Ng Tian Khean
Mobile: +65 96402808
Email: tk@waterbrooks.com.sg

Topic: Press release summary
Source: AcroMeta Group Limited

Sectors: Healthcare & Pharm, Construct, Engineering
From the Asia Corporate News Network

Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


AcroMeta Group Limited Related News
Jan 26, 2024 11:00 HKT/SGT
AcroMeta Receives Buy-Out Offer for its Controlled Environments Engineering Subsidiary
Dec 12, 2023 22:20 HKT/SGT
Acrometa Signs Strategic Cooperation Framework Agreement to Develop Co-Working Lab Space in China
Nov 29, 2023 20:00 HKT/SGT
Acrometa Posts Record Revenue of S$69.5 Million for FY2023, Continues to Pursue New Opportunities in Co-Working Lab Space Business
Nov 17, 2023 21:00 HKT/SGT
Acrometa Subsidiary Signs Two MOUs to Develop Co-Working Laboratory Space Business in China
Nov 6, 2023 21:00 HKT/SGT
Acrometa Group Signs MOU for Sand Concession, Opening New Business Opportunities in the Region
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575